Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Benzphetamine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Chemical compound}} {{Global|date=March 2025}} {{Use dmy dates|date=September 2024}} {{cs1 config |name-list-style=vanc |display-authors=6}} {{drugbox | Verifiedfields = verified | verifiedrevid = 459955085 | INN = Benzfetamine | image = Benzphetamine.svg | width = 250px | alt = | image2 = Benzphetamine-MV.png | width2 = 225px | alt2 = <!-- Clinical data --> | pronounce = | tradename = Didrex, Recede | Drugs.com = {{drugs.com|ppa|benzphetamine}} | MedlinePlus = | DailyMedID = Benzphetamine | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_AU_comment = | pregnancy_category = | dependency_liability = High<ref>{{cite web|url= http://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3294|title= Benzphetamine|author= <!--Staff writer(s); no by-line.-->|website= Toxnet|archive-url= https://web.archive.org/web/20181101101226/https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3294|archive-date= 2018-11-01|url-status= dead}}</ref> | addiction_liability = | routes_of_administration = [[Oral administration|By mouth]] | class = | ATC_prefix = None | ATC_suffix = | ATC_supplemental = <!-- Legal status --> | legal_AU = S4 | legal_AU_comment = | legal_BR = F2 | legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-07-24 |title=RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |url-status=live |archive-url=https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |archive-date=2023-08-27 |access-date=2023-08-27 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-07-25}}</ref> | legal_CA = Schedule I | legal_DE = Anlage I | legal_US = Schedule III | legal_UK = Class C | legal_EU = | legal_EU_comment = | legal_UN = <!-- N I, II, III, IV / P I, II, III, IV --> | legal_UN_comment = | legal_status = <!-- Pharmacokinetic data --> | bioavailability = | protein_bound = 75–99% | metabolism = | metabolites = • [[Dextromethamphetamine]]<br />• [[Dextroamphetamine]] | onset = | elimination_half-life = 4–6 hours<ref name="Woo2015" /> | duration_of_action = | excretion = <!-- Identifiers --> | CAS_number_Ref = {{cascite|correct|CAS}} | CAS_number = 156-08-1 | CAS_supplemental = | PubChem = 5311017 | IUPHAR_ligand = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00865 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 4470556 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 0M3S43XK27 | KEGG = D07514 | KEGG2 = D07515 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 3044 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 3545985 | NIAID_ChemDB = | PDB_ligand = | synonyms = Benzfetamine; ''d''-Benzphetamine; (+)-Benzphetamine; (''S'')-(+)-Benzphetamine; (''S'')-Benzphetamine; (2''S'')-''N''-Benzyl-''N''-methylamphetamine; ''dextro''-''N''-Benzyl-''N''-methylamphetamine; ''N''-Benzyldextromethamphetamine; (+)-''N''-Benzyl-''N'',α-dimethylphenethylamine <!-- Chemical data -->| IUPAC_name = (2''S'')-''N''-Benzyl-''N''-methyl-1-phenylpropan-2-amine | C = 17 | H = 21 | N = 1 | SMILES = N(C)(Cc1ccccc1)[C@@H](C)Cc2ccccc2 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = YXKTVDFXDRQTKV-HNNXBMFYSA-N }} '''Benzphetamine''', sold under the brand name '''Didrex''' among others, is an [[amphetamine-type stimulant]] and [[anorectic|appetite suppressant]] used short-term for [[weight loss]] along with a doctor-approved, reduced-[[calorie]] [[dieting|diet]], [[exercise]], and behavioral program. It is prescribed for [[obesity]] to people who have been unable to lose weight through exercise and dieting alone. It is a [[prodrug]] of [[dextromethamphetamine]] and [[dextroamphetamine]].<ref name="LLC2014">{{cite book|author=AHC Media, LLC|title=Pediatric Trauma Care II: A clinical reference for physicians and nurses caring for the acutely injured child|url=https://books.google.com/books?id=9fucAwAAQBAJ&pg=PA118|date=17 March 2014|publisher=AHC Media, LLC|isbn=978-1-934863-59-6|pages=118–}}</ref><ref>{{cite journal | vauthors = Cody JT, Valtier S | title = Detection of amphetamine and methamphetamine following administration of benzphetamine | journal = Journal of Analytical Toxicology | volume = 22 | issue = 4 | pages = 299–309 | year = 1998 | pmid = 9681333 | doi = 10.1093/jat/22.4.299 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Budd RD, Jain NC | doi = 10.1093/jat/2.6.241| title = Short Communication: Metabolism and Excretion of Benzphetamine: Sources of Error in Reporting Results| journal = Journal of Analytical Toxicology| volume = 2| issue = 6| pages = 241| year = 1978 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)